Raju Prasad
Chief Financial Officer · 5 filings · Latest: Aug 7, 2026
CRISPR Therapeutics AG
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CRSP | Raju Prasad | Chief Financial Officer | Mar 23, 2026 | Sale | $46.78 | 3,708 | $173.5K | 15,565 | |
CRSP | Raju Prasad | Chief Financial Officer | Mar 20, 2026 | Option Exercise | — | 6,250 | — | 19,273 | |
CRSP | Raju Prasad | Chief Financial Officer | Mar 16, 2026 | Sale | $48.26 | 9,869 | $476.3K | 13,773 | |
CRSP | Raju Prasad | Chief Financial Officer | Mar 14, 2026 | Option Exercise | — | 16,875 | — | 23,642 | |
CRSP | Raju Prasad | Chief Financial Officer | Jan 22, 2026 | Sale | $60.19 | 34,972 | $2.1M | 6,767 | |
CRSP | Raju Prasad | Chief Financial Officer | Jan 22, 2026 | Option Exercise | $45.15 | 34,972 | $1.6M | 41,739 | |
CRSP | RAJU PRASAD | — | Jan 22, 2026 | Proposed Sale | $60.19 | 34,972 | $2.1M | — | |
CRSP | RAJU PRASAD | — | Jan 6, 2026 | Proposed Sale | $60.16 | 29,700 | $1.8M | — | |
CRSP | RAJU PRASAD | — | Dec 22, 2025 | Proposed Sale | $55.95 | 10,000 | $559.5K | — |